GLPwatch
Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
NCT01403025 · Completed
Last updated 2026-05-28This clinical trial is testing the safety of the medication liraglutide in adults with type 2 diabetes by monitoring for serious side effects.
Status Completed The study has finished.
Type Observational
Participants 4,121 people
Who can join all sexes
Timeline Started 2011-07 · est. completion 2015-12
Where 1 site · Japan
What this study is testing ClinicalTrials.gov NCT01403025 ↗
Description as written by the study sponsor.
This trial is conducted in Asia. The aim of the trial is to assess the incidence rate and type of SADRs (serious adverse drug reactions).
Treatments tested
- liraglutide Drug
Once daily at a fixed timing, and subcutaneously (under the skin) in the abdomen, in the thigh or in the upper arm
| Main thing measured | The incidence of SADRs (Serious Adverse Drug Reactions) |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Conditions studied | Diabetes, Diabetes Mellitus, Type 2 |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01403025 ↗